127 related articles for article (PubMed ID: 6146808)
1. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis.
Morgan BP; Campbell AK; Compston DA
Lancet; 1984 Aug; 2(8397):251-4. PubMed ID: 6146808
[TBL] [Abstract][Full Text] [Related]
2. Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls.
Rodriguez M; Wynn DR; Kimlinger TK; Katzmann JA
Neurology; 1990 May; 40(5):855-7. PubMed ID: 2330118
[TBL] [Abstract][Full Text] [Related]
3. Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis.
Halawa I; Lolli F; Link H
Acta Neurol Scand; 1989 Aug; 80(2):130-5. PubMed ID: 2816275
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid C9 in demyelinating disease.
Compston DA; Morgan BP; Oleesky D; Fifield R; Campbell AK
Neurology; 1986 Nov; 36(11):1503-6. PubMed ID: 3762967
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of IgG and albumin in CSF and serum from multiple sclerosis patients by enzyme-linked immunosorbent assay.
Mehta PD; Mehta SP
Acta Neurol Scand; 1987 Feb; 75(2):125-9. PubMed ID: 3107335
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical analysis of the cerebrospinal fluid in multiple sclerosis: study of various formulas].
Rumbach L; Grucker M; Kiesmann M; Warter JM; Collard M
Pathol Biol (Paris); 1988 Dec; 36(10):1217-20. PubMed ID: 3070462
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid.
Johnson KP; Nelson BJ
Ann Neurol; 1977 Nov; 2(5):425-31. PubMed ID: 103485
[TBL] [Abstract][Full Text] [Related]
8. Agarose electrophoresis and immunonephelometric quantitation of cerebrospinal fluid immunoglobulins: criteria for application in the diagnosis of neurologic disease.
Pearl GS; Check IJ; Hunter RL
Am J Clin Pathol; 1984 May; 81(5):575-80. PubMed ID: 6720628
[TBL] [Abstract][Full Text] [Related]
9. The cerebrospinal fluid immunoglobulin G index as a diagnostic aid in multiple sclerosis: a Bayesian approach.
Hische EA; van der Helm HJ; van Walbeek HK
Clin Chem; 1982 Feb; 28(2):354-5. PubMed ID: 7055958
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
Andersson M; Alvarez-Cermeño J; Bernardi G; Cogato I; Fredman P; Frederiksen J; Fredrikson S; Gallo P; Grimaldi LM; Grønning M
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):897-902. PubMed ID: 8057110
[TBL] [Abstract][Full Text] [Related]
11. Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation.
Ganrot K; Laurell CB
Clin Chem; 1974 May; 20(5):571-3. PubMed ID: 4207912
[No Abstract] [Full Text] [Related]
12. CSF characteristics in early-onset multiple sclerosis.
Pohl D; Rostasy K; Reiber H; Hanefeld F
Neurology; 2004 Nov; 63(10):1966-7. PubMed ID: 15557527
[TBL] [Abstract][Full Text] [Related]
13. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.
Link H; Tibbling G
Scand J Clin Lab Invest; 1977 Sep; 37(5):397-401. PubMed ID: 337461
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of the immunoglobulin-albumin ratio compared to electrophoresis in the diagnosis of multiple sclerosis].
Rivier E; de Crousaz G; Steck A; Regli F
Schweiz Med Wochenschr; 1978 Dec; 108(52):2066-8. PubMed ID: 104382
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic usefulness of cerebrospinal fluid in multiple sclerosis.
Mehta PD
Crit Rev Clin Lab Sci; 1991; 28(3):233-51. PubMed ID: 1905549
[TBL] [Abstract][Full Text] [Related]
16. Immunoradiometric assay for human complement component C9 utilising monoclonal antibodies.
Morgan BP; Campbell AK; Luzio JP; Siddle K
Clin Chim Acta; 1983 Oct; 134(1-2):85-94. PubMed ID: 6652914
[TBL] [Abstract][Full Text] [Related]
17. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.
García-Merino A; Persson MA; Ernerudh J; Díaz-Gil JJ; Olsson T
J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1066-70. PubMed ID: 2428940
[TBL] [Abstract][Full Text] [Related]
18. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
Cognazzo A; Gerbino Promis PC; Grasso E
Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
[TBL] [Abstract][Full Text] [Related]
19. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination.
Rifai N; Christenson RH; Gelman BB; Silverman LM
Clin Chem; 1987 Jul; 33(7):1155-7. PubMed ID: 3594843
[TBL] [Abstract][Full Text] [Related]
20. A comparison between chemical analysis and magnetic resonance imaging with the clinical diagnosis of multiple sclerosis.
Papadopoulos NM; McFarlin DE; Patronas NJ; McFarland HF; Costello R
Am J Clin Pathol; 1987 Sep; 88(3):365-8. PubMed ID: 3630976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
